PCI Biotech Holding ASA: PCI Biotech interim first-half year 2022 results
Oslo (Norway), 31 August 2022 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first-half year 2022 results. Please find enclosed the report and presentation. Highlights Corporate*The
Source: finanznachrichten.de